Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original autho...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Line Kjaer Winberg [verfasserIn] |
|---|
| Format: |
Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Arthritis research & therapy - London : BioMed Central, 2003, 19(2017) |
|---|---|
| Übergeordnetes Werk: |
volume:19 ; year:2017 |
| Links: |
|---|
| DOI / URN: |
10.1186/s13075-017-1437-3 |
|---|
| Katalog-ID: |
OLC1999704169 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1999704169 | ||
| 003 | DE-627 | ||
| 005 | 20230513172035.0 | ||
| 007 | tu | ||
| 008 | 171228s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13075-017-1437-3 |2 doi | |
| 028 | 5 | 2 | |a PQ20171228 |
| 035 | |a (DE-627)OLC1999704169 | ||
| 035 | |a (DE-599)GBVOLC1999704169 | ||
| 035 | |a (PRQ)p643-917892450a7fbdbf367ced31a1cb87cfc771137e0e1e1f3d76f5e7f12433618d3 | ||
| 035 | |a (KEY)0427448220170000019000000000microparticlesfrompatientswithsystemiclupuserythem | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 0 | |a Line Kjaer Winberg |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes. | ||
| 650 | 4 | |a Granulocytes | |
| 650 | 4 | |a Neutrophils | |
| 650 | 4 | |a Rheumatology | |
| 650 | 4 | |a Arthritis | |
| 650 | 4 | |a Lupus | |
| 650 | 4 | |a Consent | |
| 650 | 4 | |a Pathogenesis | |
| 700 | 0 | |a Soren Jacobsen |4 oth | |
| 700 | 0 | |a Claus H Nielsen |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Arthritis research & therapy |d London : BioMed Central, 2003 |g 19(2017) |w (DE-627)363765530 |w (DE-600)2107602-9 |w (DE-576)379407604 |x 1478-6354 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2017 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1186/s13075-017-1437-3 |3 Volltext |
| 856 | 4 | 2 | |u https://search.proquest.com/docview/1960911968 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-NED | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2017 | ||
| author_variant |
l k w lkw |
|---|---|
| matchkey_str |
article:14786354:2017----::irprilsrmainsihytmcuueyhmtssnuerdcinfeciexgnpceadern |
| hierarchy_sort_str |
2017 |
| publishDate |
2017 |
| allfields |
10.1186/s13075-017-1437-3 doi PQ20171228 (DE-627)OLC1999704169 (DE-599)GBVOLC1999704169 (PRQ)p643-917892450a7fbdbf367ced31a1cb87cfc771137e0e1e1f3d76f5e7f12433618d3 (KEY)0427448220170000019000000000microparticlesfrompatientswithsystemiclupuserythem DE-627 ger DE-627 rakwb eng 610 DNB Line Kjaer Winberg verfasserin aut Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes. Granulocytes Neutrophils Rheumatology Arthritis Lupus Consent Pathogenesis Soren Jacobsen oth Claus H Nielsen oth Enthalten in Arthritis research & therapy London : BioMed Central, 2003 19(2017) (DE-627)363765530 (DE-600)2107602-9 (DE-576)379407604 1478-6354 nnns volume:19 year:2017 http://dx.doi.org/10.1186/s13075-017-1437-3 Volltext https://search.proquest.com/docview/1960911968 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-NED SSG-OLC-PHA SSG-OLC-DE-84 AR 19 2017 |
| spelling |
10.1186/s13075-017-1437-3 doi PQ20171228 (DE-627)OLC1999704169 (DE-599)GBVOLC1999704169 (PRQ)p643-917892450a7fbdbf367ced31a1cb87cfc771137e0e1e1f3d76f5e7f12433618d3 (KEY)0427448220170000019000000000microparticlesfrompatientswithsystemiclupuserythem DE-627 ger DE-627 rakwb eng 610 DNB Line Kjaer Winberg verfasserin aut Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes. Granulocytes Neutrophils Rheumatology Arthritis Lupus Consent Pathogenesis Soren Jacobsen oth Claus H Nielsen oth Enthalten in Arthritis research & therapy London : BioMed Central, 2003 19(2017) (DE-627)363765530 (DE-600)2107602-9 (DE-576)379407604 1478-6354 nnns volume:19 year:2017 http://dx.doi.org/10.1186/s13075-017-1437-3 Volltext https://search.proquest.com/docview/1960911968 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-NED SSG-OLC-PHA SSG-OLC-DE-84 AR 19 2017 |
| allfields_unstemmed |
10.1186/s13075-017-1437-3 doi PQ20171228 (DE-627)OLC1999704169 (DE-599)GBVOLC1999704169 (PRQ)p643-917892450a7fbdbf367ced31a1cb87cfc771137e0e1e1f3d76f5e7f12433618d3 (KEY)0427448220170000019000000000microparticlesfrompatientswithsystemiclupuserythem DE-627 ger DE-627 rakwb eng 610 DNB Line Kjaer Winberg verfasserin aut Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes. Granulocytes Neutrophils Rheumatology Arthritis Lupus Consent Pathogenesis Soren Jacobsen oth Claus H Nielsen oth Enthalten in Arthritis research & therapy London : BioMed Central, 2003 19(2017) (DE-627)363765530 (DE-600)2107602-9 (DE-576)379407604 1478-6354 nnns volume:19 year:2017 http://dx.doi.org/10.1186/s13075-017-1437-3 Volltext https://search.proquest.com/docview/1960911968 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-NED SSG-OLC-PHA SSG-OLC-DE-84 AR 19 2017 |
| allfieldsGer |
10.1186/s13075-017-1437-3 doi PQ20171228 (DE-627)OLC1999704169 (DE-599)GBVOLC1999704169 (PRQ)p643-917892450a7fbdbf367ced31a1cb87cfc771137e0e1e1f3d76f5e7f12433618d3 (KEY)0427448220170000019000000000microparticlesfrompatientswithsystemiclupuserythem DE-627 ger DE-627 rakwb eng 610 DNB Line Kjaer Winberg verfasserin aut Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes. Granulocytes Neutrophils Rheumatology Arthritis Lupus Consent Pathogenesis Soren Jacobsen oth Claus H Nielsen oth Enthalten in Arthritis research & therapy London : BioMed Central, 2003 19(2017) (DE-627)363765530 (DE-600)2107602-9 (DE-576)379407604 1478-6354 nnns volume:19 year:2017 http://dx.doi.org/10.1186/s13075-017-1437-3 Volltext https://search.proquest.com/docview/1960911968 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-NED SSG-OLC-PHA SSG-OLC-DE-84 AR 19 2017 |
| allfieldsSound |
10.1186/s13075-017-1437-3 doi PQ20171228 (DE-627)OLC1999704169 (DE-599)GBVOLC1999704169 (PRQ)p643-917892450a7fbdbf367ced31a1cb87cfc771137e0e1e1f3d76f5e7f12433618d3 (KEY)0427448220170000019000000000microparticlesfrompatientswithsystemiclupuserythem DE-627 ger DE-627 rakwb eng 610 DNB Line Kjaer Winberg verfasserin aut Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes. Granulocytes Neutrophils Rheumatology Arthritis Lupus Consent Pathogenesis Soren Jacobsen oth Claus H Nielsen oth Enthalten in Arthritis research & therapy London : BioMed Central, 2003 19(2017) (DE-627)363765530 (DE-600)2107602-9 (DE-576)379407604 1478-6354 nnns volume:19 year:2017 http://dx.doi.org/10.1186/s13075-017-1437-3 Volltext https://search.proquest.com/docview/1960911968 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-NED SSG-OLC-PHA SSG-OLC-DE-84 AR 19 2017 |
| language |
English |
| source |
Enthalten in Arthritis research & therapy 19(2017) volume:19 year:2017 |
| sourceStr |
Enthalten in Arthritis research & therapy 19(2017) volume:19 year:2017 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Granulocytes Neutrophils Rheumatology Arthritis Lupus Consent Pathogenesis |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Arthritis research & therapy |
| authorswithroles_txt_mv |
Line Kjaer Winberg @@aut@@ Soren Jacobsen @@oth@@ Claus H Nielsen @@oth@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
363765530 |
| dewey-sort |
3610 |
| id |
OLC1999704169 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1999704169</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230513172035.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">171228s2017 xx ||||| 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s13075-017-1437-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20171228</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1999704169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1999704169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)p643-917892450a7fbdbf367ced31a1cb87cfc771137e0e1e1f3d76f5e7f12433618d3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0427448220170000019000000000microparticlesfrompatientswithsystemiclupuserythem</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Line Kjaer Winberg</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Granulocytes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neutrophils</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rheumatology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arthritis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lupus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Consent</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pathogenesis</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Soren Jacobsen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Claus H Nielsen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Arthritis research & therapy</subfield><subfield code="d">London : BioMed Central, 2003</subfield><subfield code="g">19(2017)</subfield><subfield code="w">(DE-627)363765530</subfield><subfield code="w">(DE-600)2107602-9</subfield><subfield code="w">(DE-576)379407604</subfield><subfield code="x">1478-6354</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:19</subfield><subfield code="g">year:2017</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1186/s13075-017-1437-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://search.proquest.com/docview/1960911968</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-NED</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">19</subfield><subfield code="j">2017</subfield></datafield></record></collection>
|
| author |
Line Kjaer Winberg |
| spellingShingle |
Line Kjaer Winberg ddc 610 misc Granulocytes misc Neutrophils misc Rheumatology misc Arthritis misc Lupus misc Consent misc Pathogenesis Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes |
| authorStr |
Line Kjaer Winberg |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)363765530 |
| format |
Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
OLC |
| remote_str |
false |
| illustrated |
Not Illustrated |
| issn |
1478-6354 |
| topic_title |
610 DNB Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes Granulocytes Neutrophils Rheumatology Arthritis Lupus Consent Pathogenesis |
| topic |
ddc 610 misc Granulocytes misc Neutrophils misc Rheumatology misc Arthritis misc Lupus misc Consent misc Pathogenesis |
| topic_unstemmed |
ddc 610 misc Granulocytes misc Neutrophils misc Rheumatology misc Arthritis misc Lupus misc Consent misc Pathogenesis |
| topic_browse |
ddc 610 misc Granulocytes misc Neutrophils misc Rheumatology misc Arthritis misc Lupus misc Consent misc Pathogenesis |
| format_facet |
Aufsätze Gedruckte Aufsätze |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
nc |
| author2_variant |
s j sj c h n chn |
| hierarchy_parent_title |
Arthritis research & therapy |
| hierarchy_parent_id |
363765530 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Arthritis research & therapy |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)363765530 (DE-600)2107602-9 (DE-576)379407604 |
| title |
Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes |
| ctrlnum |
(DE-627)OLC1999704169 (DE-599)GBVOLC1999704169 (PRQ)p643-917892450a7fbdbf367ced31a1cb87cfc771137e0e1e1f3d76f5e7f12433618d3 (KEY)0427448220170000019000000000microparticlesfrompatientswithsystemiclupuserythem |
| title_full |
Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes |
| author_sort |
Line Kjaer Winberg |
| journal |
Arthritis research & therapy |
| journalStr |
Arthritis research & therapy |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
txt |
| author_browse |
Line Kjaer Winberg |
| container_volume |
19 |
| class |
610 DNB |
| format_se |
Aufsätze |
| author-letter |
Line Kjaer Winberg |
| doi_str_mv |
10.1186/s13075-017-1437-3 |
| dewey-full |
610 |
| title_sort |
microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes |
| title_auth |
Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes |
| abstract |
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes. |
| abstractGer |
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes. |
| abstract_unstemmed |
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-NED SSG-OLC-PHA SSG-OLC-DE-84 |
| title_short |
Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes |
| url |
http://dx.doi.org/10.1186/s13075-017-1437-3 https://search.proquest.com/docview/1960911968 |
| remote_bool |
false |
| author2 |
Soren Jacobsen Claus H Nielsen |
| author2Str |
Soren Jacobsen Claus H Nielsen |
| ppnlink |
363765530 |
| mediatype_str_mv |
n |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1186/s13075-017-1437-3 |
| up_date |
2024-07-03T15:06:07.374Z |
| _version_ |
1803570818449408000 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1999704169</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230513172035.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">171228s2017 xx ||||| 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s13075-017-1437-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20171228</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1999704169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1999704169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)p643-917892450a7fbdbf367ced31a1cb87cfc771137e0e1e1f3d76f5e7f12433618d3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0427448220170000019000000000microparticlesfrompatientswithsystemiclupuserythem</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Line Kjaer Winberg</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. (F, G) Leukocytes from a healthy control were incubated with LPS in combination with MPs from 20 SLE patients and 10 healthy controls in the presence of NHS for 30 min at 37 °C. Contents of (F) MPO and (G) MMP-9 in the supernatants shown as median values after subtraction of background (unstimulated cells). N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Granulocytes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neutrophils</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rheumatology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arthritis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lupus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Consent</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pathogenesis</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Soren Jacobsen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Claus H Nielsen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Arthritis research & therapy</subfield><subfield code="d">London : BioMed Central, 2003</subfield><subfield code="g">19(2017)</subfield><subfield code="w">(DE-627)363765530</subfield><subfield code="w">(DE-600)2107602-9</subfield><subfield code="w">(DE-576)379407604</subfield><subfield code="x">1478-6354</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:19</subfield><subfield code="g">year:2017</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1186/s13075-017-1437-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://search.proquest.com/docview/1960911968</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-NED</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">19</subfield><subfield code="j">2017</subfield></datafield></record></collection>
|
| score |
7.402669 |